Jerry has over a decade of experience in the patent profession, specialising in chemical and mechanical technologies, with experience of medical device, chemical formulation, solid state and process chemistries, composites and other materials cases. As well as drafting and prosecuting patent applications, he provides FTO and strategic IP advice and handles oppositions and other oral proceedings before the EPO.
He has a broad range of expertise dealing with medical devices, including pulse oximetry, laryngoscopy and latterly a wide range of transcatheter devices. Jerry’s practice also includes chemical and materials technologies, renewable energy and petrochemical technologies, aerospace and composites technologies, and hydraulic and pneumatic systems.
Jerry spent time in industrial R&D and university technology transfer, before joining the patent profession in 2007.
Jerry has extensive experience of drafting and prosecuting applications before the EPO and UKIPO, and managing international patent portfolios. In addition, he has advised his clients on patent infringement and validity, and assisted in due diligence on behalf of his clients.
Jerry holds a first class M. Chem from the University of Oxford and went on to obtain a PhD from the University of British Columbia, Vancouver, Canada, in the field of solid state NMR spectroscopy.
On returning to the UK Jerry spent time in industrial R&D and university technology transfer, before joining the patent profession in 2007. He moved to the Edinburgh office of HGF in September 2015, from another top-tier UK firm.
University of Oxford
University of British Columbia
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.